Sen-Jam Pharmaceutical

  • ABOUT US
    • MISSION
    • TEAM
    • HISTORY
  • INDICATIONS
    • UPENDING SIDE EFFECTS
    • MARKET OPPORTUNITY
  • THE SCIENCE
    • PREVENTING SIDE EFFECTS
    • HOW EXULTA WORKS
  • PRAISES
  • UPDATES
  • CONTACT

How Exulta Works

Sen-Jam is pursuing the Exulta™ offering as a means to mitigate the painful side effects associated with several important areas of health concern.  The first is Opioid dependency, tolerance and withdrawal,  Secondarily, we have evidence supporting the effectiveness of our product to help mitigate side effects associated with arthritis, vaccine administration and the flu-like aches and pains associated with the common cold.  In addition, our product has been shown to effectively mitigate hangover symptoms by preventing them beforehand. All of these indications are covered by one simple, powerful fixed dose combination drug that is here to make a positive difference in the lives of millions of people worldwide.

We currently believe that Exulta™ acts by stabilizing the innate immune system, helping your body maintain homeostasis when you encounter a flu vaccine, opioid withdrawal, the common cold and, of course, hangover side-effects. Ensuring that you’re at your best every day.

Current research and clinical discoveries suggest that these challenging circumstances (and we are exploring others) cause the body to release immunological substances that result in painful side-effects or symptoms.

In our veisalgia (alcohol hangover) model study, subjects claimed 60-80% reduction of side effects including headache, fatigue, thirst and nausea.  These same side effects, which occur with Common Cold, Vaccine Administration and Opioid Withdrawal can also be mitigated.

Exulta™ for Opioid Tolerance and Dependence works by a unique mechanism.  By stabilizing glial cell activity, the detrimental side effects of opioids can be inhibited.

  • ABOUT US
  • INDICATIONS
  • THE SCIENCE
  • PRAISES
  • UPDATES
  • CONTACT

Copyright © 2019 · Sen-Jam Pharmaceutical

  • Facebook
  • Linkedin
  • Twitter